Investing.com - Edwards Lifesciences (NYSE:EW) reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $1.38 on revenue of $1.09B. Analysts polled by Investing.com anticipated EPS of $1.33 on revenue of $1.05B. That compared to EPS of $1.24 on revenue of $972.1M in the same period a year earlier. The company had reported EPS of $1.32 on revenue of $993M in the previous quarter.
Edwards Lifesciences shares gained 2.89% to trade at $201.00 in after-hours trade following the report.
Edwards Lifesciences shares gained 2.89% to trade at $201.00 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are up 27.54%, outperforming the S&P 500 which is up 21.32% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On Tuesday, July 16, 2019, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Novartis ADR earnings beat analyst's expectations on Thursday, with second quarter EPS of $1.34 on revenue of $11.76B. Investing.com analysts expected EPS of $1.21 on revenue of $11.49B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar